Facebook
Twitter
LinkedIn
Forward
Division of Newborn Medicine APP Spring Pharmacology Conference
Target Audience
Nurse Practitioner, Pharmacist, Physician, Physician Assistant, CRNA, all APPs.
Learning Objectives
12:00pm-1:00pm Neonatal Arrythmias
Title: Pharmacology and Application of Anti-Arrhythmic Drugs in the Neonate
Presenter: Tyler H. Harris, M.D. (Faculty, Attending) and Lindsey Haack, M.D. (Fellow)
Heart and Vascular Institute, Division of Pediatric Cardiology
Learning Objectives:
Understand the common arrhythmias of the neonate
Describe the classification system for Antiarrhythmic drugs (AADs)
Understand the indications and side effects of commonly used AADs in the neonate
1:00pm-2:00pm: Patent Ductus Arteriosus
Title: Patent Ductus Arteriosus (PDA): Updates and Recent Literature...To Treat or Not To Treat, that is the Question
Presenter: Brian C. King, M.D. (Faculty, Attending)
Division of Newborn Medicine
Learning Objectives:
Review pharmacokinetics and pharmacodynamics of drugs used in neonates to close the patent ductus arteriosus
Discuss the benefits and pitfalls of common drugs used to close the PDA: indomethacin, ibuprofen and acetaminophen
Review most recent clinical trial data available and leading to the best, evidence-based medicine approach to the premature infant with PDA
2:00pm-3:00pm: Pharmacology & BPD
Title: Let’s Have a Heart to Lung: Pulmonary Hypertension in Bronchopulmonary Dysplasia
Presenters: Jennifer Shenk, PharmD, BCPPS & Melinda Miller, PharmD, BCPS
Children’s Hospital of Pittsburgh, Pharmacy
Learning Objectives:
Describe the incidence and underlying pathophysiology of pulmonary hypertension (PAH) in infants with bronchopulmonary dysplasia (BPD)
Review pharmacologic options for the treatment of acute and chronic PAH
Apply evidence-based recommendations to PAH patient scenarios
Additional Information
| Attachment | Size |
|---|---|
 Conference Agenda.pdf | 163.18 KB |
Conference Agenda:
12pm-1pm Neonatal Arrythmias
Title: Pharmacology and Application of Anti-Arrhythmic Drugs in the Neonate
Presenter: Tyler H. Harris, M.D. (Faculty, Attending) and Lindsey Haack, M.D. (Fellow)
Heart and Vascular Institute, Division of Pediatric Cardiology
Learning Objectives:
Understand the common arrhythmias of the neonate
Describe the classification system for Antiarrhythmic drugs (AADs)
Understand the indications and side effects of commonly used AADs in the neonate
1pm-2pm: Patent Ductus Arteriosus
Title: Patent Ductus Arteriosus (PDA): Updates and Recent Literature...To Treat or Not To Treat, that is the Question
Presenter: Brian C. King, M.D. (Faculty, Attending)
Division of Newborn Medicine
Learning Objectives:
Review pharmacokinetics and pharmacodynamics of drugs used in neonates to close the patent ductus arteriosus
Discuss the benefits and pitfalls of common drugs used to close the PDA: indomethacin, ibuprofen and acetaminophen
Review most recent clinical trial data available and leading to the best, evidence-based medicine approach to the premature infant with PDA
2pm-3pm: Pharmacology & BPD
Title: Let’s Have a Heart to Lung: Pulmonary Hypertension in Bronchopulmonary Dysplasia
Presenters: Jennifer Shenk, PharmD, BCPPS & Melinda Miller, PharmD, BCPS
Children’s Hospital of Pittsburgh, Pharmacy
Learning Objectives:
Describe the incidence and underlying pathophysiology of pulmonary hypertension (PAH) in infants with bronchopulmonary dysplasia (BPD)
Review pharmacologic options for the treatment of acute and chronic PAH
Apply evidence-based recommendations to PAH patient scenarios
Conference Adjournment: 3pm
Faculty Disclosure:
No members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 3.0 contact hours.
Pharmacy (CPE)
This knowledge-based activity provides 3.0 contact hours of continuing pharmacy education credit.
Physician Assistant (AAPA)
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 3.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 3.00 AAPA Category I CME
- 3.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
- 3.00 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 3.00 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 3.00 Attendance
Questions?
Contact: Alexandra Mastro, PA-C, MPAS
E-mail: [email protected]